Table 2.
Prevalence of antibodies in cervical washes of women.
| Control (n = 45), no (%) | Primary infection (n = 44), no (%) | Recurrent infection (n = 81), no (%) | |
|---|---|---|---|
| Ctr-IgG+ | 3 (7) | 35 (78)a | 19 (23) |
| Ctr-IgA+ | 3 (7) | 23 (52)b | 30 (37) |
| cHSP10 IgG+ | 5 (11) | 9 (20) | 35 (43)c |
| cHSP10 IgA+ | 0 (0) | 4 (9) | 20 (25)d |
| cHSP60 IgG+ | 4 (9) | 11 (25) | 36 (44)e |
| cHSP60 IgA+ | 4 (9) | 12 (27) | 27 (33) |
Ctr = Chlamydia trachomatis
a
P < 0·0001
b
P = 0·04
c
P = 0·0008
d
P = 0·007
e
P = 0·004.
P-values are in comparison with both controls and patient groups. cHSP: chlamydial heat shock protein.